Healthcare Providers’ Technology Imperatives | Market Insights™
Healthcare providers’ short-term technology imperatives, including low-hanging fruit, long-term best, opportunistic bets, and slow-burning opportunities
Healthcare providers’ short-term technology imperatives, including low-hanging fruit, long-term best, opportunistic bets, and slow-burning opportunities
Service lines driving IT demand across demand categories
The insurance industry is not yet mature enough to move core business applications to cloud, but many are considering making the move
Insurance AO buyers’ emerging priorities and key investment themes
Analytics, cloud, and mobility are the primary driver of digital adoption in the Global In-house Centers (GICs)
Digital investment priorities in North American enterprises: Top investment priorities over the next 12 to 24 months
Capital markets ITO buyers trends and implications for service providers
Key Investment Themes in Capital Markets Application Outsourcing (AO)
The recently announced acquisition of Merge is one in a string of initiatives by IBM to increase both its market presence and depth of offerings to the healthcare sector. With birth rates increasing in many parts of the world and the aging population growing in developed countries, the race is on for data driven and highly efficient healthcare.
IBM is clearly targeting this market. Its recent activities have included:
The US$1 billion acquisition of Merge brings IBM a medical imaging platform to combine with Watson’s image data and analytics capabilities and an extended client base. Excellent and Elementary, Dr. Watson.
With these initiatives, IBM is building specialist competences, to capture, analyze, and recommend treatments or actions that would help healthcare providers, payers, pharmaceuticals, as well as individuals achieve positive health outcomes.
Gaining a wide range of capabilities in specific areas has helped IBM generate specific segment revenue in good and bad times. For example, its large number of information management and WebSphere portfolio acquisitions (e.g., Cognos, Netezza, and SPSS, to name but a few) has seen segment-specific revenues maintain steady growth over the years.
If IBM was to successfully combine its deep specialization in healthcare with Watson’s cognitive computing to enhance its services, it could gain a big edge over competitors at a time when demand is set to grow. At the moment we are seeing more of IBM in healthcare IT infrastructure modernization contracts than data-driven care provisioning and support services. Recent examples include:
These types of contracts give IBM opportunities to tap into new solution and services openings at existing clients.
Other challenges for IBM’s intelligent and data driven healthcare offerings include:
IBM is going all out when it comes to showcasing Watson as a competitive differentiator. In an uncharacteristic move (and a sign of the times), it has launched Watson Developer Cloud, an open platform for developers to build apps on top of Watson for industry-specific solutions (through a set of APIs and SDKs). It is also working with app developers such as Decibel, Epic, Fluid, Go Moment, MD Buyline, TalkSpace, and Welltok to build apps embedded on Watson technology, thereby, rounding up a robust ecosystem. It is abundantly clear that IBM views healthcare as the principal vertical where Watson’s computing prowess can make its mark. In the meantime other service providers are likely to build or acquire their own cognitive capabilities to challenge IBM on pricing and specialist offerings.
Photo credit: Flickr
Banks’ emerging priorities have implications for IT service providers
© 2011-2022 Everest Global, Inc.